Carlos Rodriguez-Galindo

Carlos Rodriguez-Galindo, M.D., is the director of the St. Jude Global program at St. Jude Children’s Research Hospital and an executive vice president within the organization. He is also the chair of the Department of Global Pediatric Medicine and holds the Four Stars of Chicago Endowed Chair in International Pediatric Research. In addition to his global work, Dr. Rodriguez-Galindo’s clinical research has focused in retinoblastoma, bone sarcomas, histiocytic disorders and rare childhood cancers, and has been the primary investigator of several clinical studies at St. Jude and Dana-Farber/Boston Children’s Cancer Center. Dr. Rodriguez-Galindo is the Chair of the Rare Tumors Committee at the Children’s Oncology Group (COG) and the primary investigator of COG studies for nasopharyngeal carcinoma, adrenocortical carcinoma, and recurrent malignant germ cell tumors. He is also the past-President of the Histiocyte Society and co-PI of the frontline LCH-IV study.